Latest news

Clear filters

Mathys & Squire trainees excel in latest exams

In what has been a particularly difficult year for all students across the world, with much uncertainty and logistical changes, we are delighted to announce a record number of exam success for… read more…

Level up your IP strategy: the patentability of video games in the UK and Europe

In this article for The Patent Lawyer, Andrew White and Conor McGuinness develop key insights into patenting video games with exploration of unsuccessful and successful case examples Image… read more…

No ‘Get Out of Jail Free’ card for Hasbro

The General Court (‘GC’) has refused an appeal by Hasbro Inc (‘Hasbro’) regarding the decision to partially invalidate a registration of its MONOPOLY mark on the ground of bad… read more…

Application of Article 53(a) EPC – Considering the morality of pharmaceutical inventions

The European Patent Office (EPO)’s Technical Board of Appeal 3301, in recent decision T 1553/15, has provided guidance on the patentability exclusion under Article 53(a) EPC, which prescribes that… read more…

Mathys & Squire Consulting launched to formalise successful commercial IP services offering

The launch of Mathys & Squire Consulting follows the exciting acquisition of leading IP consulting firm Coller IP in 2017, when Mathys & Squire sought to develop its IP strategy and… read more…

Protecting non-therapeutic methods at the EPO

Like many patent offices, the EPO does not allow applicants to claim methods for treatment of the human or animal body by surgery or therapy (Article 53(c) EPC) Such exclusions are historically… read more…

Why IP matters to the UK video game industry

In this article for PCR, Mathys & Squire Partner Andrew White and Technical Assistant Conor McGuinness, look at the patentability of computer games in Europe and the UK and address the common… read more…

New EPO Guidelines for Examination: Key changes for the life sciences

A new edition of the EPO Guidelines for Examination (‘the guidelines’) came into force on 1 March 2021 Relevant to life sciences, this edition includes a new subsection detailing EPO practice… read more…

G1/19: EPO Enlarged Board of Appeal hands down decision on patentability of simulations and computer-implemented inventions

Further to our article in July 2020 on the EPO Enlarged Board of Appeal’s hearing in G1/19, the Enlarged Board has now published its long-awaited decision relating to the patentability of… read more…

1 31 32 33 34 35 36 37 38 39 40 41 82